• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

DF3/MUC1乳腺癌抗原与Grb2及Sos/Ras交换蛋白的关联。

Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.

作者信息

Pandey P, Kharbanda S, Kufe D

机构信息

Division of Cancer Pharmacology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts 02115, USA.

出版信息

Cancer Res. 1995 Sep 15;55(18):4000-3.

PMID:7664271
Abstract

The DF3/MUC1 mucin-like glycoprotein is aberrantly overexpressed in human breast carcinomas. Although the precise functional role of this protein remains unclear, the cytoplasmic tail contains potential tyrosine phosphorylation sites for binding to Src homology 2 (SH2) domains. In the present studies using human MCF-7 breast cancer cells, we show that tyrosine phosphorylated DF3 directly interacts with the SH2 domain of the adaptor protein Grb2. The findings indicate that a pYTNP site in DF3 is responsible for this interaction. The results also demonstrate that the DF3/Grb2 complex associates with the guanine nucleotide exchange protein Sos. Because Sos binds to the SH3 domains of Grb2 and, thereby, associates with Ras at the cell membrane, formation of a DF3/Grb2/Sos complex supports a role for DF3 in intracellular signaling.

摘要

DF3/MUC1粘蛋白样糖蛋白在人类乳腺癌中异常过表达。尽管该蛋白的确切功能作用尚不清楚,但其胞质尾部含有与Src同源2(SH2)结构域结合的潜在酪氨酸磷酸化位点。在使用人MCF-7乳腺癌细胞的本研究中,我们表明酪氨酸磷酸化的DF3直接与衔接蛋白Grb2的SH2结构域相互作用。这些发现表明DF3中的一个pYTNP位点负责这种相互作用。结果还证明DF3/Grb2复合物与鸟嘌呤核苷酸交换蛋白Sos相关联。由于Sos与Grb2的SH3结构域结合,从而在细胞膜处与Ras相关联,DF3/Grb2/Sos复合物的形成支持了DF3在细胞内信号传导中的作用。

相似文献

1
Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein.DF3/MUC1乳腺癌抗原与Grb2及Sos/Ras交换蛋白的关联。
Cancer Res. 1995 Sep 15;55(18):4000-3.
2
Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.Disabled-2(Dab2)是Grb2的一个SH3结构域结合伙伴。
Oncogene. 1998 Mar 26;16(12):1561-9. doi: 10.1038/sj.onc.1201678.
3
The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.哺乳动物Grb2的SH2和SH3结构域将表皮生长因子(EGF)受体与Ras激活剂mSos1偶联起来。
Nature. 1993 May 6;363(6424):83-5. doi: 10.1038/363083a0.
4
p21Ras activation by the guanine nucleotide exchange factor Sos, requires the Sos/Grb2 interaction and a second ligand-dependent signal involving the Sos N-terminus.鸟嘌呤核苷酸交换因子Sos对p21Ras的激活需要Sos/Grb2相互作用以及涉及Sos N端的第二个配体依赖性信号。
Oncogene. 1996 Nov 21;13(10):2055-65.
5
Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2.在过表达erbB-2的人乳腺癌细胞中Ras信号通路的激活
Oncogene. 1994 Dec;9(12):3601-8.
6
Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2-SOS complex in insulin receptor signaling.在胰岛素受体信号传导中,Sam68与Grb2的SH3结构域结合,将GAP招募至Grb2 - SOS复合物。
J Cell Biochem. 2002;86(1):99-106. doi: 10.1002/jcb.10198.
7
Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.GRB2与受体蛋白酪氨酸磷酸酶α的紧密结合是由SH2结构域和C末端SH3结构域介导的。
EMBO J. 1996 Jun 17;15(12):3016-27.
8
Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.Grb2的SH2结构域的晶体结构:聚焦于一种新型高亲和力抑制剂的结合
J Mol Biol. 2002 Feb 1;315(5):1167-77. doi: 10.1006/jmbi.2001.5299.
9
MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes.丝裂原活化蛋白激酶对mSos1的磷酸化作用促进了mSos1-Shc复合物和mSos1-表皮生长因子受体复合物的解离。
Oncogene. 1995 Oct 5;11(7):1417-26.
10
SH3 domains of the adapter molecule Grb2 complex with two proteins in T cells: the guanine nucleotide exchange protein Sos and a 75-kDa protein that is a substrate for T cell antigen receptor-activated tyrosine kinases.衔接分子Grb2的SH3结构域与T细胞中的两种蛋白质结合:鸟嘌呤核苷酸交换蛋白Sos和一种75 kDa的蛋白质,该蛋白质是T细胞抗原受体激活的酪氨酸激酶的底物。
J Biol Chem. 1994 May 13;269(19):14081-7.

引用本文的文献

1
The Interplay between T Cells and Cancer: The Basis of Immunotherapy.T 细胞与癌症的相互作用:免疫疗法的基础。
Genes (Basel). 2023 Apr 28;14(5):1008. doi: 10.3390/genes14051008.
2
Canonical and truncated transglutaminase-2 regulate mucin-1 expression and androgen independency in prostate cancer cell lines.经典型和截短型转谷氨酰胺酶-2 调节前列腺癌细胞系中黏蛋白-1 的表达和雄激素非依赖性。
Cell Death Dis. 2023 May 9;14(5):317. doi: 10.1038/s41419-023-05818-9.
3
Emergence of in Mammals for Adaptation of Barrier Epithelia.哺乳动物中用于屏障上皮适应的[具体事物]的出现。(原文“Emergence of in Mammals for Adaptation of Barrier Epithelia.”中“of”后面缺少具体内容,导致句子不完整,只能按现有结构勉强翻译)
Cancers (Basel). 2022 Sep 30;14(19):4805. doi: 10.3390/cancers14194805.
4
MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma.MUC1负责毛蕊异黄酮在胰腺导管腺癌中的促转移潜能。
Am J Cancer Res. 2022 Jul 15;12(7):3242-3258. eCollection 2022.
5
Novel insights into the roles and therapeutic implications of MUC1 oncoprotein via regulating proteins and non-coding RNAs in cancer.通过调节癌症中的蛋白质和非编码 RNA 揭示 MUC1 癌蛋白在肿瘤发生中的作用和治疗意义。
Theranostics. 2022 Jan 1;12(3):999-1011. doi: 10.7150/thno.63654. eCollection 2022.
6
Mucin1 and Mucin16: Therapeutic Targets for Cancer Therapy.黏蛋白1和黏蛋白16:癌症治疗的靶点
Pharmaceuticals (Basel). 2021 Oct 17;14(10):1053. doi: 10.3390/ph14101053.
7
MUC1 mediates Pneumocystis murina binding to airway epithelial cells.MUC1 介导肺孢子菌肺炎结合气道上皮细胞。
Cell Microbiol. 2020 Jun;22(6):e13182. doi: 10.1111/cmi.13182. Epub 2020 Feb 19.
8
MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.MUC1-C 抑制人癌细胞中的 RASSF1A 肿瘤抑制因子。
Oncogene. 2019 Nov;38(47):7266-7277. doi: 10.1038/s41388-019-0940-1. Epub 2019 Aug 21.
9
Identification of Crucial Candidate Genes and Pathways in Glioblastoma Multiform by Bioinformatics Analysis.基于生物信息学分析鉴定胶质母细胞瘤中的关键候选基因和通路。
Biomolecules. 2019 May 24;9(5):201. doi: 10.3390/biom9050201.
10
The Role of the Cell Surface Mucin MUC1 as a Barrier to Infection and Regulator of Inflammation.细胞表面黏蛋白 MUC1 作为感染屏障和炎症调节剂的作用。
Front Cell Infect Microbiol. 2019 Apr 24;9:117. doi: 10.3389/fcimb.2019.00117. eCollection 2019.